Advanced Cell Technology, Inc. ;, a leader in the field of regenerative medicine, announced today that it has received clearance from the U.K. Medicines and Healthcare products Regulatory Agency to begin treating patients as part of a Phase 1/2 clinical trial for Stargardt’s Macular Dystrophy using retinal pigment epithelium derived from human embryonic stem cells .

Read the rest here:
ACT Receives Approval for First Human Embryonic Stem Cell Trial in Europe

(Ivanhoe Newswire) OSTORA, a new oral drug made of salmon calcitonin, was in its third phase of study to determine if it effectively treated postmenopausal osteoporosis. The researchers deemed it safe and effective. The ORACAL study was a Phase II …

Continued here:
Oral Calcitonin Tablet Safe for Treating Osteoporosis

Tarsa Therapeutics today reported that it presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA, the company’s oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.

See the rest here:
Tarsa reports positive data from OSTORA Phase III ORACAL trial for postmenopausal osteoporosis

The osteoporosis drug Prolia (denosumab) produced positive results in a Phase 2 study extension, Reuters reports. Results of the study showed that for postmenopausal women with osteoporosis [low bone mass] who received up to eight years of continued treatment with Prolia, bone mineral density increased on average 16.8 percent at the lumbar spine and 6.9 percent in the total hip, Amgen Inc., the …

View post:
Osteoporosis Drug Proven Effective in Clinical Trial

Tarsa Therapeutics today presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA-, the company’s oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.

Here is the original post:
Positive data from Tarsa’s OSTORA Phase III trial on postmenopausal osteoporosis

( BioCom Partners ) Last week’s FDA review highlighted issues with long-term use of bisphosphonates for osteoporosis. Yet women have few treatment options.

Originally posted here:
Osteoporosis Phase III data at 2011 ASBMR Show oral calcitonin tablet is safe and effective

Using a patient’s own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial.

Read more:
Bone marrow stem cell therapy safe for acute stroke, study suggests

Using a patient’s own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston (UTHealth).

The rest is here:
Bone marrow stem cell therapy safe for acute stroke: report

Using a patient’s own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston (UTHealth).

Continue reading here:
Bone Marrow Stem Cell Therapy Safe for Acute Stroke

( University of Texas Health Science Center at Houston ) Using a patient’s own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at the University of Texas Health Science Center at Houston (UTHealth).

Read more from the original source:
UTHealth reports bone marrow stem cell therapy safe for acute stroke